Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.430
-0.080 (-5.30%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Revenue
In the year 2024, Whitehawk Therapeutics had annual revenue of $25.98M with 6.69% growth. Whitehawk Therapeutics had revenue of $7.24M in the quarter ending December 31, 2024, with 14.43% growth.
Revenue (ttm)
$25.98M
Revenue Growth
+6.69%
P/S Ratio
1.51
Revenue / Employee
$649,575
Employees
40
Market Cap
67.84M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
WHWK News
- 4 weeks ago - Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals - PRNewsWire
- 5 weeks ago - Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company - PRNewsWire